• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脂肪变性指数与子宫内膜癌风险的关联:一项横断面研究。

Association Between Hepatic Steatosis Index and Endometrial Cancer Risk: A Cross-Sectional Study.

作者信息

Zheng Lili, Lei Huifang, Tang Xiaoyi, Zheng Yuanyin, Wu Qiuzhen, Chen Peixuan, Chen Yanhong, Cai Liangzhi

机构信息

Department of Gynecology, Mindong Hospital Affiliated to Fujian Medical University, Ningde, People's Republic of China.

Department of Laboratory, Mindong Hospital Affiliated to Fujian Medical University, Ningde, People's Republic of China.

出版信息

Int J Womens Health. 2025 Mar 17;17:825-833. doi: 10.2147/IJWH.S497621. eCollection 2025.

DOI:10.2147/IJWH.S497621
PMID:40123758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11927498/
Abstract

PURPOSE

To investigate the relationship between hepatic steatosis index (HSI) and endometrial cancer (EC) and its diagnostic value for EC.

PATIENTS AND METHODS

A total of 114 patients with pathologically diagnosed EC in Mindong Hospital, Ningde City, Fujian Province from 2016 to 2022 were retrospectively included as the EC group. A total of 175 patients with pathologically confirmed benign endometrial lesions (endometrial polyps and uterine submucosal fibroids) in the same hospital during the same period were selected as the control group. Non-parametric test were used to compare the differences in HSI and non-alcoholic fatty liver disease (NAFLD) between the two groups, and the diagnostic value of HSI and NAFLD levels on EC was analysed. The cut-off point of continuous variables was determined by receiver operating characteristic (ROC) curve analysis. Logistic regression analysis was used to calculate odds ratios (ORs).

RESULTS

The results showed that compared with the control group, serum GGT, CA125, HDL-C and HSI were significantly increased in the EC group (P<0.05). 27.19% of the EC patients (31/114) and 12% of the control group (21/175) had NAFLD, and the difference between the two groups was statistically significant (P<0.05). The results of univariate logistic regression analysis showed that GGT, CA125, HDL-C, HSI and NAFLD were significantly correlated with the occurrence of EC (P<0.05). Further multivariate logistic regression analysis showed that CA125 and HSI elevation were independent risk factors for EC (P<0.05).

CONCLUSION

NAFLD is closely associated with EC, and elevated HSI is an independent risk factor for EC.

摘要

目的

探讨肝脏脂肪变性指数(HSI)与子宫内膜癌(EC)的关系及其对EC的诊断价值。

患者与方法

回顾性纳入2016年至2022年在福建省宁德市闽东医院病理诊断为EC的114例患者作为EC组。同期在同一医院选取175例经病理证实为良性子宫内膜病变(子宫内膜息肉和子宫黏膜下肌瘤)的患者作为对照组。采用非参数检验比较两组HSI及非酒精性脂肪性肝病(NAFLD)的差异,并分析HSI和NAFLD水平对EC的诊断价值。连续变量的截断点通过受试者工作特征(ROC)曲线分析确定。采用逻辑回归分析计算比值比(OR)。

结果

结果显示,与对照组相比,EC组血清γ-谷氨酰转移酶(GGT)、癌抗原125(CA125)、高密度脂蛋白胆固醇(HDL-C)和HSI显著升高(P<0.05)。27.19%的EC患者(31/114)和12%的对照组患者(21/175)患有NAFLD,两组差异有统计学意义(P<0.05)。单因素逻辑回归分析结果显示,GGT、CA125、HDL-C、HSI和NAFLD与EC的发生显著相关(P<0.05)。进一步多因素逻辑回归分析显示,CA125升高和HSI升高是EC的独立危险因素(P<0.05)。

结论

NAFLD与EC密切相关,HSI升高是EC的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/13989beeb2c4/IJWH-17-825-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/67e53beb3ac8/IJWH-17-825-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/f9e900c412d0/IJWH-17-825-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/13989beeb2c4/IJWH-17-825-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/67e53beb3ac8/IJWH-17-825-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/f9e900c412d0/IJWH-17-825-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c80/11927498/13989beeb2c4/IJWH-17-825-g0003.jpg

相似文献

1
Association Between Hepatic Steatosis Index and Endometrial Cancer Risk: A Cross-Sectional Study.肝脂肪变性指数与子宫内膜癌风险的关联:一项横断面研究。
Int J Womens Health. 2025 Mar 17;17:825-833. doi: 10.2147/IJWH.S497621. eCollection 2025.
2
Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.验证脂肪肝指数和肝脂肪变性指数在阻塞性睡眠呼吸暂停低通气综合征成人非酒精性脂肪肝疾病筛查中的应用。
Chin Med J (Engl). 2019 Nov 20;132(22):2670-2676. doi: 10.1097/CM9.0000000000000503.
3
Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population.成人非酒精性脂肪变性中,肝脂肪变性指数作为非侵入性诊断工具与肝脏超声检查的比较。
Gastroenterol Hepatol Bed Bench. 2022;15(4):360-365. doi: 10.22037/ghfbb.v15i4.2480.
4
Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.肝脂肪变性指数(HSI)在筛查 2 型糖尿病患者代谢性脂肪性肝病中的作用。
Pan Afr Med J. 2020 Nov 25;37:270. doi: 10.11604/pamj.2020.37.270.9087. eCollection 2020.
5
The relationship between hepatic steatosis index and hypertension: NHANES 2011-2018.肝脏脂肪变性指数与高血压之间的关系:2011 - 2018年美国国家健康与营养检查调查(NHANES)
BMC Cardiovasc Disord. 2025 Apr 17;25(1):289. doi: 10.1186/s12872-025-04744-2.
6
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience.家族性高胆固醇血症合并非酒精性脂肪性肝病患者加用 PCSK9 抑制剂治疗后脂肪变性生物标志物和炎症谱分析:单脂质中心真实世界经验。
Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):869-879. doi: 10.1016/j.numecd.2020.11.009. Epub 2020 Nov 13.
7
Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.用于诊断绝经前女性多囊卵巢综合征伴或不伴非酒精性脂肪性肝病的内脏脂肪指数。
Maturitas. 2018 Oct;116:1-7. doi: 10.1016/j.maturitas.2018.06.013. Epub 2018 Jul 4.
8
Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.肝脂肪变指数和脂肪肝指数与 2 型糖尿病患者颈动脉粥样硬化的关系。
Int J Med Sci. 2021 Jul 23;18(14):3280-3289. doi: 10.7150/ijms.62010. eCollection 2021.
9
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy.肝脂肪变性指数在抗病毒治疗的慢性乙型肝炎患者脂肪肝检测中的应用。
Gut Liver. 2021 Jan 15;15(1):117-127. doi: 10.5009/gnl19301.
10
The Predictive Ability of Hepatic Steatosis Index for Gestational Diabetes Mellitus and Large for Gestational Age Infant Compared with Other Noninvasive Indices Among Chinese Pregnancies: A Preliminary Double-center Cohort Study.在中国孕妇中,与其他非侵入性指标相比,肝脂肪变性指数对妊娠期糖尿病和大于胎龄儿的预测能力:一项初步的双中心队列研究。
Diabetes Metab Syndr Obes. 2021 Dec 16;14:4791-4800. doi: 10.2147/DMSO.S335364. eCollection 2021.

本文引用的文献

1
Polycystic ovary syndrome and endometrial cancer risk: results from a nationwide cohort study.多囊卵巢综合征与子宫内膜癌风险:一项全国性队列研究结果。
Am J Epidemiol. 2024 Oct 7;193(10):1399-1406. doi: 10.1093/aje/kwae061.
2
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
3
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肝细胞癌和肝外癌症风险。
Lancet Gastroenterol Hepatol. 2024 Feb;9(2):159-169. doi: 10.1016/S2468-1253(23)00275-3.
4
Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.中国癌症概况及与美国的比较:发病率、死亡率、生存率、分期和归因于危险因素的综合分析。
Sci China Life Sci. 2024 Jan;67(1):122-131. doi: 10.1007/s11427-023-2423-1. Epub 2023 Sep 21.
5
Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.代谢综合征评分作为子宫内膜癌淋巴结转移预测列线图的指标。
BMC Cancer. 2023 Jul 4;23(1):622. doi: 10.1186/s12885-023-11053-4.
6
Value of TCT combined with HPV and CA125 in early cervical cancer screening in a medical examination population.TCT联合HPV及CA125在体检人群早期宫颈癌筛查中的价值
Cell Mol Biol (Noisy-le-grand). 2022 Sep 30;68(9):160-164. doi: 10.14715/cmb/2022.68.9.25.
7
Risk prediction models for endometrial cancer: development and validation in an international consortium.子宫内膜癌风险预测模型:国际合作研究中的建立与验证。
J Natl Cancer Inst. 2023 May 8;115(5):552-559. doi: 10.1093/jnci/djad014.
8
Endometrial cancer and obesity: Addressing the awkward silence.子宫内膜癌与肥胖:打破尴尬的沉默
JAAPA. 2023 Jan 1;36(1):28-31. doi: 10.1097/01.JAA.0000902884.01725.a3.
9
Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features.血清CA125和HE4作为检测子宫内膜癌及相关高危特征的生物标志物。
Diagnostics (Basel). 2022 Nov 17;12(11):2834. doi: 10.3390/diagnostics12112834.
10
Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome.二甲双胍可改善非肥胖型多囊卵巢综合征患者的肝脏脂肪变性指数。
J Clin Med. 2022 Jul 24;11(15):4294. doi: 10.3390/jcm11154294.